Anivia Medical Holdings develops the SG1000 Pump Console, an open-system extracorporeal device designed to drive disposable centrifugal pump heads for patients with cardiovascular diseases. This technology addresses the need for versatile and interoperable solutions in critical care, enhancing patient outcomes and preserving quality of life.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with cardiovascular diseases often require extracorporeal support using centrifugal pump systems. Existing systems can lack versatility due to closed architectures that limit interoperability with different disposable pump heads, potentially restricting clinical options.
Solution
Anivia Medical Holdings offers the SG1000 Pump Console, an open-system extracorporeal device designed to drive disposable centrifugal pump heads. The SG1000 is a key component of the Anivia System, allowing interoperability with various disposable brands, offering flexible configurations to meet diverse clinical demands. This versatility enables clinicians to tailor extracorporeal support to specific patient needs and preferences. The system aims to improve patient outcomes and quality of life by providing a flexible and adaptable solution for cardiovascular support in critical care settings.
Target Audience
The primary target audience includes healthcare providers in critical care settings, such as hospitals and cardiac centers, who require versatile extracorporeal support solutions for patients with cardiovascular diseases.
Features
- Open-system architecture for interoperability with various disposable centrifugal pump heads.
- Designed for use in extracorporeal blood circuits.
- Flexible configurations to meet diverse clinical demands.
- Key component of the Anivia System.